Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model.

Mol Oncol · 2025 · PMC12515692 · PMID 40129297

Europe PMC DOI

hedged sentence

0.0527

closest p · 1.1× alpha

0.0527

boldest claim

The sentences

a strong trendP = 0.0527so close (0.05 < p ≤ 0.1)

Moreover, a strong trend with respect to the decrease in the BLI signals within the treatment groups compared to placebo was observed in the liver ( P = 0.0527) and rear limbs ( P = 0.0591) (Fig. 2A–I ).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.